KPF
CELU icon

K2 Principal Fund’s Celularity CELU Stock Holding History

K2 Principal Fund’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-27,093
Closed -$2.73M – 373
2021
Q1 		$2.73M Buy
27,093
+7,093
+35% +$727K 0.22% 121
2020
Q4 		$2.2M Hold
20,000
– – 0.19% 148
2020
Q3 		$2.1M Hold
20,000
– – 0.31% 109
2020
Q2 		$2.04M Buy
+20,000
New +$1.99M 0.32% 95

Other funds holding CELU

WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

K2 Principal Fund's CELU Position: Q2 2021 in Review

K2 Principal Fund sold out of Celularity (CELU) in Q2 2021, closing a stake of 27,093 shares — an estimated $2.73M sold.

K2 Principal Fund first reported a position in CELU in Q2 2020 and held it in 4 quarters. The position peaked at $2.73M in Q1 2021. 33 funds tracked by Wall St. Rank hold CELU as of Q2 2021.

  • K2 Principal Fund reported no remaining Celularity position as of Q2 2021 after selling out during the quarter.
  • K2 Principal Fund sold 27,093 Celularity shares in Q2 2021, an estimated $2.73M.
  • K2 Principal Fund first reported a position in Celularity in Q2 2020 and held it in 4 quarters.
  • K2 Principal Fund's Celularity position peaked at $2.73M in Q1 2021.
  • 33 funds tracked by Wall St. Rank held Celularity as of Q2 2021.

Based on K2 Principal Fund's 13F filing for Q2 2021, filed 13 Aug 2021.